MedTrace Logo

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

NCT06196593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-01-09

No results posted yet for this study

Summary

The objective of this study was to evaluate the clinical and patient reported outcomes after bilateral implantation of the AcrySof™ IQ Vivity™ Toric intraocular lens.

Conditions

  • Cataract Senile
  • Intraocular Lens Complication

Interventions

DEVICE

AcrySof™ IQ Vivity™ Toric intraocular lens

Uneventful phacoemulsification and implantation of IOL

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • LEC Eye Centre

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-04-30
Completion
2023-04-30
FDA Device
Yes

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06196593 on ClinicalTrials.gov